Ultra sound-guided thyroid fine needle aspiration by Vassallo, Pierre
ultrasound (US)-guided FNA lends itself particularly well to lesions in superficial organs such as the thyroid, lymph nodes and the breast. However, since it is less traumatic than core 
biopsy, it is safer for use in highly vascular organs such as the 
thyroid gland. Smaller nodules are more amnable to FNA, while 
larger nodules are better sampled with core biopsy. 
focal thyroId lesIons
The Society of Radiologists in Ultrasound suggests that FNA 
should be considered for a thyroid nodule 1.0cm or more at 
the largest diameter if microcalcifications are present and for a 
nodule 1.5cm or larger if the nodule is solid or if there are coarse 
calcifications within the nodule.
In cases of multiple thyroid nodules, the risk of an individual 
nodule being cancerous is decreased but the prevalence of thyroid 
cancer does not differ between patients with a solitary nodule 
and those with multiple nodules. Recent literature indicates 
that patients with multiple thyroid nodules have the same risk 
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of developing thyroid malignancy as patients with solitary 
thyroid nodules. Therefore in the presence of multiple nodules, 
FNA is indicated. However a meticulous search for suspicious 
ultrasound features should be made in order to identify the more 
suspicious nodules as sampling of all nodules is frequently not 
practical.
US features that are suggestive of malignancy include 
microcalcifications (Fig 1), marked hypoechogenicity (Fig 2), 
an irregular or microlobulated margin (Fig 3), a longitudinal 
dimension larger than the transverse dimension (Fig 4), high 
intrinsic vascularity (Fig 5), direct tumor invasion of adjacent soft 
tissue (Fig 6), and metastasis to one or more lymph nodes (fig 7). 
In cases with multiple thyroid nodules, US characteristics 
are more useful than nodule size for identifying nodules that are 
likely to be malignant. If only the dominant or largest nodule is 
aspirated, a thyroid cancer may be missed (Fig 8 a, b). Diagnostic 
US therefore should be performed to characterize all thyroid 
nodules prior to considering which one(s) to biopsy.
MedICAl IMAgIng
fIne needle aspIratIon (fna) Is a MInIMally InVasIVe Method for saMplIng focal lesIons 
that uses a sMall gauge hypoderMIc needle (20-24 gauge) to obtaIn cells for MIcroscopIc 
analysIs. thIs Is In contrast to core bIopsy whIch obtaIns a core of tIssue usIng larger 
gauge cuttIng needles (14-18 gauge). both fna and core bIopsIes are classIfIed as closed 
or percutaneous bIopsIes as opposed to open bIopsy that Is obtaIned durIng surgery.
Figure 1. Transverse ultrasound scan through the 
right thyroid lobe and isthmus showing multiple 
microcalcifications (arrows) in an ill-defined 
hypoechoic lesion. 
Figure 2. Transverse scan through at left thyroid lobe 
lesion (arrow) that shows marked hypoechogenicity.
Figure 3. (a) 
Transverse scan 
through the left 
thyroid lobe showing 
a hypoechoic lesion 
with irregular 
microlobulated 
margins (arrowheads) 
and (b) longitudinal 
scan through the 
left thyroid lobe 
showing a moderately 
echogenic lesion with 
one ill-defined margin 
(arrowheads).
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dIffuse thyroId lesIons
Among patients with autoimmune diseases such as Hashimoto 
thyroiditis, the rate of thyroid malignancy is similar to that among 
patients with a non-symptomatic thyroid gland. In cases in which 
Hashimoto thyroiditis manifests as a nodular lesion mimicking a 
thyroid neoplasm, FNA must be performed to rule out lymphoma 
and papillary carcinoma, either of which may coexist with 
Hashimoto thyroiditis (Fig 9 a, b). FNA is also required in cases 
of diffuse rapid enlargement of the thyroid gland, especially in 
patients older than 50 years, to rule out anaplastic carcinoma, 
metastasis, and lymphoma (Fig 10 a, b).
hIgh rIsK of thyroId cancer
The threshold for biopsy of a thyroid nodule in a patient with 
one or more risk factors for thyroid cancer is lower than that 
for biopsy in a patient without such risk factors. Risk factors for 
thyroid cancer include a family history of thyroid cancer, a history 
of head and neck irradiation, male gender, age of less than 30 years 
or more than 60 years, and a previous diagnosis of type 2 multiple 
endocrine neoplasia.
procedure for perforMIng an us-guIded thyroId fna 
Prior to performing thyroid FNA, the reasons for performing 
the procedure should be explained to the patient. These are (1) to 
reach a diagnosis and (2) possibly avoid surgery. The procedure 
for performing a thyroid FNA must be explained and informed 
consent obtained from the patient. 
One should ask about known coagulation disorders and 
whether the patient is taking anticoagulation treatment; if no 
history of coagulation disorder or anticoagulation medication 
exists, it is not necessary to perform coagulation studies prior to 
FNA. If core biopsy is contemplated, coagulation studies are best 
performed prior to the biopsy. 
Significant complications are rare. Most frequent (but also 
rare) complications are subcapsular haematomas (Fig 11). Even 
rarer is extensive extracapsular bleeding into the neck. Both 
complications are treated conservatively. 
At the start of the procedure, the patient is placed in the 
supine position with a pillow under the shoulders to improve 
neck extension. The skin is cleansed with chlorhexidine solution, 
which is also used as the US medium (replacing US gel). Local 
anaesthetic is administered to skin and subcuteneous tissues with 
1-2mL 1% lidocaine hydrochloride solution. 
Initial scanning in the horizontal plane is performed to 
locate the lesion and evaluation with Colour Doppler Ultrasound 
identifies the location of large blood vessels that need to be 
avoided to minimize the likelihood of blood contamination of the 
specimen. The patient is instructed not to swallow or speak while 
the needle is in the thyroid gland.
The probe is placed in the transverse plane with the needle/
syringe parallel to the plane of the probe with a medio-lateral or 
latero-medial approach (Fig 12a). Having the needle parallel to 
the plane of the beam improves visualisation of the needle tip (Fig 
12b). 
A 24-gauge needle is inserted into the solid portion of the 
nodule under US visualisation and when the needle tip is in 
position, it is moved vigorously in and out while being rotated to 
dislodge as much tissue as possible from the nodule into the needle 
bore. This is ideally performed until a small amount of tissue 
is seen in the hub of the needle. Aspiration may or may not be 
Figure 7. Longitudinal scan through an 
enlarged right carotid lymph node (arrows) 
that also shows central necrosis (*). 
Figure 4. Transverse scan through the left thyroid 
lobe showing a hypoechoic lesion with a height 
measurement (arrows) greater than the width 
measurement. 
Figure 8 (a) & (b). 
Sagittal scan through the 
left thyroid lobe showing 
the clinically palpable 
thyroid mass as a 2.5-cm 
well-circumscribed 
isoechoic nodule (* in a), 
a finding suggestive of a 
benign nodule. Superior 
to the said nodule 
however, was an 0.8cm 
non-palpable hypoechoic 
mass with a height 
exceeding its width (arrow 
in b). FNA confirmed 
papillary carcinoma in the 
non-palpable mass and 
adenomatous hyperplasia 
in the palpable mass. 
Figure 9. A rapidly growing mass was seen in the 
left thyroid lobe in a man with chronic Hashimoto 
thyroiditis. (a) Transverse US scan shows a 
diffusely enlarged and heterogeneously hypoechoic 
thyroid gland. (b) Coronal PET-18FDG scan 
shows increased uptake in the left thyroid lobe 
(arrow). FNA biopsy showed findings characteristic 
of diffuse large B-cell lymphoma.
Figure 6. Transverse scan through the right thyroid 
lobe showing a hypoechoic lesion (between calipers) 
with direct invasion (arrowheads) of the adjacent 
sternohyoid muscle (SHM). 
Figure 5. Longitudinal scan through a left thyroid 
lobe lesion showing marked intrinsic hypervascularity 
(arrows) on Colour Doppler imaging.
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performed during the to-and-fro movement, but is best avoided in 
very vascular lesions as it is likely to cause specimen contamination 
with blood. 
During the procedure, the needle tip should be placed into 
different parts of the nodule avoiding blood vessels; this will 
improve sample quality and reduces the sample inadequacy rate. 
Aspiration should not be performed while the needle is withdrawn. 
The procedure may be repeated especially if the sample 
obtained appears bloody. 
After the procedure, adhesive plaster is applied, and the patient 
should be instructed to manually compress the skin entry site for 
a minimum of 30 minutes. The patient should be instructed to 
contact hospital staff or visit the emergency room if neck swelling 
occurs on the way home or at home.
If a lesion contains both cystic and solid components, the solid 
component should be sampled (Fig 13). If the lesion contains a 
large fluid component, this is best to aspirate the fluid first and then 
perform a FNA on the remaining solid component (Fig 14). 
A repeat FNA biopsy should be considered if there is 
discordance between the findings at imaging and those at cytologic 
analysis (Fig 15), a growing mass, a recurrent cyst, or an inadequate 
FNA sample. At least 3 months should be allowed to elapse after 
the initial FNA biopsy. The 3-month time lag before repeat FNA is 
recommended to avoid problems in cytologic interpretation that 
may be posed by reparative cellular atypia (e.g. marked nuclear 
chromatin clearing, grooves, or inclusions that may be mistaken for 
evidence of papillary carcinoma).
For follow-up of thyroid nodules with an initial benign 
cytologic diagnosis and without clinical or radiologic findings 
suggestive of malignancy, imaging surveillance is recommended 
rather than repeat US-guided FNA biopsy. If nodule size is stable, 
the interval before the next follow-up clinical examination or US 
evaluation may be prolonged.
conclusIon
US-guided FNA is useful for the diagnosis of palpable or 
non-palpable thyroid nodules. The routine use of this biopsy 
procedure has caused profound changes in the management of 
thyroid nodules. FNA biopsy allows prompt identification and 
treatment of thyroid malignancies and avoidance of unnecessary 
surgery in patients with benign lesions, thereby improving 
the overall quality of life for patients with thyroid nodules. 
Furthermore, FNA helps guide treatment and helps reduce the 
cost of care.
The adequacy of cytologic specimens depends on several 
factors, including the nodule characteristics and the FNA 
technique used. As the person performing FNA gains experience 
and as lesion targeting and localization with US become more 
accurate, the rate of sample inadequacy should decrease.
To optimize the usefulness of FNA, every centre should strive 
to attain and maintain a high level of expertise in all aspects 
of aspiration and interpretation and, toward that end, should 
establish clinical guidelines tailored to its patient population and 
FNA biopsy results.  
Figure 10. Diffuse enlargement of the thyroid gland in a patient with 
a history of colon cancer. (a) Axial CT scan shows a diffusely enlarged 
thyroid gland (arrows). (b) US scan shows a diffusely enlarged and 
heterogeneously isoechoic thyroid gland (arrows). FNA biopsy 
analysis showed a poorly differentiated adenocarcinoma with features 
identical to those seen in an earlier colon cancer specimen.
Figure 11. A subcapsular 
haematoma following FNA (arrows).
Figure 12. Needle 
inserted parallel 
to ultrasound 
beam (a) allows 
visualisation of 
the full course of 
the needle (arrows 
in b).
Figure 13. Transverse scan of the left 
thyroid lobe shows a large lesion with mixed 
echogenicity, consisting of a predominant 
cystic portion (*) and a mural nodule 
containing microcalcifications (arrows). 
Approximately 3mL of haemorrhagic 
fluid were aspirated from the nodule at 
palpation-guided FNA biopsy and the 
cytologic results were non-diagnostic. 
Results of subsequent US-guided FNA 
biopsy of the mural nodule showed 
papillary carcinoma.
Figure 14. Optimal needle biopsy technique in a largely cystic papillary carcinoma. (a) US image shows a mass with mixed 
echogenicity. (b) US image obtained at FNA shows the needle tip as an echogenic dot (arrow) during initial aspiration of 
the fluid component of the cystic mass. (c) Subsequent US image shows the needle tip (arrow) placed in the remaining solid 
portion of the lesion from which the cytologic sample is obtained. 
Figure 15. Transverse (a) and longitudinal (b) US images 
show a 1cm-diameter, microlobulated, heterogeneous 
hypoechoic thyroid mass (arrows) with a height 
that exceeds its lateral dimension and with internal 
microcalcifications. Cytologic analysis of an initial FNA 
specimen showed clusters of follicular epithelial cells, a 
finding suggestive of adenomatous hyperplasia. Due to the 
discordance between the imaging appearance and cytologic 
findings, surgery was performed. A 1.1cm papillary 
carcinoma was found.
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